Urinary polyamine levels are markers of altered T lymphocyte proliferation/loss and rejection in heart transplant patients

J. R. Womble, Douglas F Larson, J. G. Copeland, D. H. Russell

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The studies of urinary polyamine excretion in heart transplant patients reported in this article indicate that total urinary polyamine excretion is increased one to three days before a biopsy-proved rejection in conventionally treated patients, the acetylputrescine to N1-acetylspermidine ratio becomes elevated before rejection in cyclosporine-treated patients, and the response to elevated ATG therapy during rejection can be evaluated by monitoring urinary polyamine concentrations. We conclude that daily monitoring of urinary polyamine levels may provide a noninvasive biochemical marker that precedes rejection and which parallels the extent of T lymphocyte suppression during the course of immunosuppressive drug therapy.

Original languageEnglish (US)
Pages (from-to)1573-1575
Number of pages3
JournalTransplantation Proceedings
Volume16
Issue number6
StatePublished - 1984

Fingerprint

Polyamines
T-Lymphocytes
Transplants
Immunosuppressive Agents
Cyclosporine
Biomarkers
Biopsy
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Urinary polyamine levels are markers of altered T lymphocyte proliferation/loss and rejection in heart transplant patients. / Womble, J. R.; Larson, Douglas F; Copeland, J. G.; Russell, D. H.

In: Transplantation Proceedings, Vol. 16, No. 6, 1984, p. 1573-1575.

Research output: Contribution to journalArticle

@article{ae852bd9af654d3ead80a2b605404a63,
title = "Urinary polyamine levels are markers of altered T lymphocyte proliferation/loss and rejection in heart transplant patients",
abstract = "The studies of urinary polyamine excretion in heart transplant patients reported in this article indicate that total urinary polyamine excretion is increased one to three days before a biopsy-proved rejection in conventionally treated patients, the acetylputrescine to N1-acetylspermidine ratio becomes elevated before rejection in cyclosporine-treated patients, and the response to elevated ATG therapy during rejection can be evaluated by monitoring urinary polyamine concentrations. We conclude that daily monitoring of urinary polyamine levels may provide a noninvasive biochemical marker that precedes rejection and which parallels the extent of T lymphocyte suppression during the course of immunosuppressive drug therapy.",
author = "Womble, {J. R.} and Larson, {Douglas F} and Copeland, {J. G.} and Russell, {D. H.}",
year = "1984",
language = "English (US)",
volume = "16",
pages = "1573--1575",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Urinary polyamine levels are markers of altered T lymphocyte proliferation/loss and rejection in heart transplant patients

AU - Womble, J. R.

AU - Larson, Douglas F

AU - Copeland, J. G.

AU - Russell, D. H.

PY - 1984

Y1 - 1984

N2 - The studies of urinary polyamine excretion in heart transplant patients reported in this article indicate that total urinary polyamine excretion is increased one to three days before a biopsy-proved rejection in conventionally treated patients, the acetylputrescine to N1-acetylspermidine ratio becomes elevated before rejection in cyclosporine-treated patients, and the response to elevated ATG therapy during rejection can be evaluated by monitoring urinary polyamine concentrations. We conclude that daily monitoring of urinary polyamine levels may provide a noninvasive biochemical marker that precedes rejection and which parallels the extent of T lymphocyte suppression during the course of immunosuppressive drug therapy.

AB - The studies of urinary polyamine excretion in heart transplant patients reported in this article indicate that total urinary polyamine excretion is increased one to three days before a biopsy-proved rejection in conventionally treated patients, the acetylputrescine to N1-acetylspermidine ratio becomes elevated before rejection in cyclosporine-treated patients, and the response to elevated ATG therapy during rejection can be evaluated by monitoring urinary polyamine concentrations. We conclude that daily monitoring of urinary polyamine levels may provide a noninvasive biochemical marker that precedes rejection and which parallels the extent of T lymphocyte suppression during the course of immunosuppressive drug therapy.

UR - http://www.scopus.com/inward/record.url?scp=0021709458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021709458&partnerID=8YFLogxK

M3 - Article

C2 - 6390864

AN - SCOPUS:0021709458

VL - 16

SP - 1573

EP - 1575

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 6

ER -